Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer
Fumihiko Ando(Nippon Medical School), Yoshiko Iwai(Nippon Medical School)
Cited by 6
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis
|Arthritis & Rheumatism|2013|83